News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...

"These findings reinforce the use of dapagliflozin, 10 mg, or other SGLT2 inhibitors when the therapeutic goal is to reduce ...

The price negotiations for the additional 15 drugs selected will be handled by the incoming Trump administration and, if ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

Medicare beneficiaries may pay less for 15 additional prescription drugs as early as 2027 as part of the next round of federal regulators' price negotiations with pharmaceutical manufacturers.

They included popular blood thinners Xarelto and Eliquis and diabetes drugs Jardiance and Januvia. Drug company executives told investors during earnings calls that they did not expect the ...